Dow Down0.25% Nasdaq Down0.26%

Merrimack Pharmaceuticals, Inc. (MACK)

-NasdaqGM
7.03 Down 0.07(0.99%) 4:00PM EDT
|After Hours : 7.03 0.00 (0.00%) 4:52PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 27,815   13,034   7,823   6,856  
Cost of Revenue -   -   -   -  
Gross Profit 27,815   13,034   7,823   6,856  
Operating Expenses
Research Development33,795  30,324  30,055  37,630  
Selling General and Administrative7,921  6,224  6,010  5,150  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (13,901) (23,514) (28,242) (35,924)
Income from Continuing Operations
Total Other Income/Expenses Net181  271  373  107  
Earnings Before Interest And Taxes(13,720)(23,243)(27,869)(35,817)
Interest Expense4,570  4,511  4,479  3,946  
Income Before Tax(18,290)(27,754)(32,348)(39,763)
Income Tax Expense -   -   -   -  
Minority Interest181  169  (711)132  
Net Income From Continuing Ops(18,109)(27,585)(33,059)(39,631)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (18,109) (27,585) (33,059) (39,631)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (18,109) (27,585) (33,059) (39,631)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.